Meeting
2024 ASCO Annual Meeting
ctDNA monitoring for breast cancer at high risk of recurrence: Interim analysis of JCOG1204A1.
Authors
Yoichi Naito
Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan
Yoichi Naito , Yukinori Ozaki , Hitoshi Tsuda , Keita Sasaki , Keisuke Kanato , Takashi Hojo , Norikazu Masuda , Fumikata Hara , Tadahiko Shien , Hiroji Iwata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 518)
DOI
10.1200/JCO.2024.42.16_suppl.518
Abstract #
518
Poster Bd #
110
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.
First Author: Bin Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study.
First Author: Jhe-Cyuan Guo
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Multicenter study of circulating tumor DNA in patients with pancreatic cancer using a personalized panel: ARTEMIS-PC prospective observational trial.
First Author: Edward D. Esplin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA).
First Author: Christopher Hanyoung Lieu